Clinical trialNCT00883246CompletedInterventional

Study of SilverHawk®/TurboHawk® in Lower Extremity Vessels (DEFINITIVE™ LE)

SponsorMedtronic EndovascularEnrollment800ClaudicationCritical Limb IschemiaPeripheral Arterial Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the study is to evaluate the intermediate and long-term effectiveness of stand-alone atherectomy treatment of peripheral arterial disease in the legs.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

James McKinsey, MD
The New York Presbyterian/Columbia University
Principal Investigator
clinicaltrials.gov ↗
Lawrence Garcia, MD
St. Elizabeth's Medical Center, Tuft's University School of Medicine
Principal Investigator
clinicaltrials.gov ↗
Professor Thomas Zeller
Herz-Zentrum Bad Krozingen Germany
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2009
Primary completion: 30 Jun 2012
Completion: 30 Jun 2012
Last update posted: 4 Jun 2019
Registered enrollment: 800
Registry id: NCT00883246

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.